MOTIVATE Course 3: Prevention of MOH

MOTIVATE Course 3: Prevention of MOH

1 Category 2 points with the RACGP

1 Core PDP point

All participants will be awarded a certificate of completion for self-reporting to other colleges

Duration: 30 minutes

Treatment of MOH may be difficult, and so it is important for patients to understand how to prevent this condition in the first place. As a healthcare professional, learn how to recognise patients at risk of MOH and educate them on how to avoid falling into the cyclical trap of overusing their headache medications.

Learning objectives:
Upon completing this course, participants will be able to:

  • List the classes of medications used to prevent chronic migraine;
  • Differentiate treatment for infrequent severe headaches and frequent episodic headaches;
  • Outline a plan to address the most common barriers to managing MOH and codeine-withdrawal effects;
  • Explain the interdisciplinary (between GPs and pharmacists) management of MOH;
  • Put a reminder system in place that would make use of the different monitoring strategies (e.g. headache diaries, support from both GPs and pharmacists, use of clinical measures of headache-related disability) to assess patient compliance to preventive treatment.

  • Associate Professor Richard Stark, Alfred Hospital, Melbourne, Victoria
  • Professor Mieke Van Driel, School of Medicine, University of Queensland, Herston, Queensland
  • Associate Professor Treasure McGuire, School of Pharmacy, University of Queensland, Queensland; Faculty of Health Sciences & Medicine, Bond University, Gold Coast, Queensland
  • Dr Brett McFarlane, The Australian College of Pharmacy, Canberra, Australian Capital Territory
  • Professor Deborah Turnbull, School of Psychology, University of Adelaide, South Australia

    • Royal Australian College of General Practitioners:
      • 1 Category Two QI&CPD points
      • Activity no. 109006
    • Australian College of Rural and Remote Medicine:
      • 1 Core PDP point
      • Activity no. 10380
    • Pharmacists and nurses are invited to access this continuing professional development activity. At the end, a certificate may be downloaded as proof of completion.

Dr Lara Mihaljevic
General Practitioner
Drummoyne Medical Centre, Victoria Road, Drummoyne, NSW

  • Faculty
    • Associate Professor Richard Stark: Co-authored a clinical paper sponsored by Pfizer on the safety of eletriptan. Between 2012 and 2014 received consulting and lecture fees from Allergan and lecture fees from MSD on chronic migraine
    • Professor Mieke Van Driel: No conflict of interest
    • Associate Professor Treasure McGuire: No conflict of interest
    • Dr Brett McFarlane: No conflict of interest
    • Professor Deborah Turnbull: Received research grants and co-authored papers on hypertension sponsored by pharmaceutical companies, including Pfizer Pty. Ltd., between 1999 and 2006
  • GP reviewer
    • Dr Lara Mihaljevic: No conflict of interest
  • Non-faculty: employees of In Vivo Academy involved in producing the content of this course, Aishwarya Sridharan, Tina Garcia, Monica Kurniawan and Lisa Sullivan, declare no conflict of interest.

You are not enrolled in this course. Click the following button to take this course